(Q54562647)

1 June 2018

title

IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma. (English)

1 reference

1 June 2018

0 references

1 reference

Li-Li Feng

1

1 reference

1 June 2018

Jun-Ming Gao

series ordinal

2

1 reference

1 June 2018

Pei-Pei Li

series ordinal

3

1 reference

1 June 2018

Xin Wang

series ordinal

4

1 reference

1 June 2018

publication date

4 September 2011

1 reference

1 June 2018

Journal of Clinical Immunology

published in

1 reference

1 June 2018

volume

31

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

1084-1094

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s10875-011-9584-9

exact match

0 references

cites work

Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Treatment of mantle cell lymphoma: targeting the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Inflammation and cancer: a failure of resolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Suppression of an established immune response by UVA--a critical role for mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Mast cells in the development of adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Mast cells and cancer--no longer just basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

IL-9 in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Mast cells are essential intermediaries in regulatory T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Transient regulatory T-cells: a state attained by all activated human T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Regulation of mast cell development by inflammatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9584-9

Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate

21 January 2018

1 reference

12 December 2020

CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy

1 reference

12 December 2020

Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

1 reference

12 December 2020

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course

1 reference

12 December 2020

Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.

1 reference

12 December 2020

Classical and alternative pathways of mast cell activation.

1 reference

12 December 2020

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

1 reference

12 December 2020

Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis

1 reference

12 December 2020

IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis

1 reference

12 December 2020

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

12 December 2020

HSP70 is associated with endothelial activation in placental vascular diseases.

1 reference

12 December 2020

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

1 reference

12 December 2020

10.1007/S10875-011-9584-9

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018